When it comes to development-ready assets, timing is everything. Larvotto Resources has just released a highly compelling Definitive Feasibility Study (DFS) for its Hillgrove Antimony-Gold Project in New South Wales—and it’s arrived at the right time. Gold prices are flying. Antimony prices are surging. Even tungsten is starting to catch a bid. Hillgrove is set to become a key player in a world hungry for critical minerals and strategic metals.

The Radium Hill Project in South Australia has long held historical significance as the site of the country’s first major uranium mine. What was once seen primarily as a uranium deposit is now re-emerging as a polymetallic system rich in scandium and rare earth elements (REEs). With new assays from Heavy Rare Earths Limited (ASX: HRE), this overlooked potential is becoming increasingly apparent—and economically compelling.

When we talk about "high-grade" in gold exploration, the term can sometimes lose its meaning in a market awash with numbers and drilling updates. But now and then, an announcement cuts through the noise, and Aurumin's latest results from the Gwendolyn deposit at the Johnson Range Gold Project do just that.

If there was ever a time when a company needed to make a statement, it’s in the first weeks after acquiring a new asset. And for Kaiser Reef Limited (ASX:KAU), their early run at the Henty Gold Mine hasn’t just been good—it’s been headline-worthy.

Macro Metals (ASX:M4M) is not chasing headlines, and that’s exactly why it stands out. In a sector often dominated by bold claims and speculative positioning, Macro is taking the quieter but arguably more resilient approach—scaling into a dual-core strategy of iron ore exploration and fully integrated mining services.

In a world grappling with stress and sleeplessness, The Calmer Co. International Limited (ASX: CCO) is emerging as a standout in the wellness beverage market. This Brisbane-based company, known for its innovative kava-infused offerings, has just posted a headline-grabbing 104% year-on-year growth in Amazon USA sales, reaching AUD $203,000 in April 2025 alone.

NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) has made a decisive move with its proposed acquisition of StemSmart™, a patented mesenchymal stromal cell (MSC) technology. This isn’t just another biotech transaction — it signals a strategic leap into the fast-growing field of regenerative medicine, positioning NSB to capitalise on one of the most promising frontiers in modern healthcare.

Astute investors will vouch that there is no such thing as a perfect investment opportunity, and at the Samso platform, we agree and we encourage followers to instead look for the ideal Risk-Reward proposition. However. Investors continue to look for that perfect investment opportunity that is, for some reason is extremely hard to find.

When a junior gold producer strategically adds a proven asset like the Henty Gold Mine to its portfolio, it doesn’t just reshape the company—it often redefines its position in the gold space.

In a fast-evolving education sector dominated by digital disruption and shifting learner expectations, OpenLearning Limited (ASX: OLL) continues to chart a bold course through its AI-powered Learning Management System. At the heart of this story is a recent milestone: a debt-to-equity conversion with the Education Centre of Australia (ECA), the company’s largest shareholder, which underscores long-term confidence in OpenLearning’s direction.